Bell Biosystems
Bell Biosystems, a research-stage biotechnology company, develops tools that accelerate innovations in oncology and cell therapy research.
Launch date
Employees
Market cap
-
Enterprise valuation
€14—21m (Dealroom.co estimates Apr 2015.)
San Francisco California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$1.5m | Seed | ||
| N/A | $2.1m | Series A | |
$3.8m | Series A | ||
| Total Funding | €6.7m | ||
Related Content
Recent News about Bell Biosystems
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.